-
1مؤتمر
المؤلفون: Coates, L, Ramirez, J, Mcgonagle, D, Aydin, S, Zimmermann, M, Nantel, F, Shawi, M, Rampakakis, E, Nash, P, Mease, PJ
مصطلحات موضوعية: Clinical sciences, Immunology, Science & Technology, Life Sciences & Biomedicine, Rheumatology, Enthesitis, Psoriatic arthritis
الوقت: 2023-05-31 to 2023-06-03
العلاقة: Annals of the Rheumatic Diseases; EULAR 2023 European Congress of Rheumatology, 31 May - 3 June. Milan, Italy; EULAR 2023 European Congress of Rheumatology; Coates, L; Ramirez, J; Mcgonagle, D; Aydin, S; Zimmermann, M; Nantel, F; Shawi, M; Rampakakis, E; Nash, P; Mease, PJ, Early Skin and Early Enthesitis Responses in Psoriatic Arthritis Patients Treated With Guselkumab Associate With Long-term Response: Post Hoc Analysis Through 2 Years of a Phase 3 Study, Annals of the Rheumatic Diseases, 2023, 82, pp. 1137-1137; http://hdl.handle.net/10072/429795Test
الإتاحة: https://doi.org/10.1136/annrheumdis-2023-eular.2581Test
http://hdl.handle.net/10072/429795Test -
2مؤتمر
المؤلفون: Tillett, W, Coates, L, Vis, M, Merola, JF, Soriano, E, Perate, M, Shawi, M, Zimmermann, M, Rampakakis, E, Sharaf, M, Nash, P, Helliwell, P
مصطلحات موضوعية: Clinical sciences, Immunology, Science & Technology, Life Sciences & Biomedicine, Rheumatology, Psoriatic arthritis
الوقت: 2023-05-31 to 2023-06-03
العلاقة: Annals of the Rheumatic Diseases; EULAR 2023 European Congress of Rheumatology, 31 May - 3 June. Milan, Italy; EULAR 2023 European Congress of Rheumatology; Tillett, W; Coates, L; Vis, M; Merola, JF; Soriano, E; Perate, M; Shawi, M; Zimmermann, M; Rampakakis, E; Sharaf, M; Nash, P; Helliwell, P, Minimal Important Difference (mid), Minimal Detectable Change (mdc), and Disease Activity Thresholds for Two Novel Composite Instruments (3 Vas, 4 Vas) in Patients with Psoriatic Arthritis: Pooled Analysis of Three Phase 3 Studies, Annals of The Rheumatic Diseases, 2023, 82, pp. 343-344; http://hdl.handle.net/10072/429937Test
الإتاحة: https://doi.org/10.1136/annrheumdis-2023-eular.2237Test
http://hdl.handle.net/10072/429937Test -
3مؤتمر
المؤلفون: Rahman, P, Coates, L, Nash, P, Deodhar, A, Nantel, F, Rampakakis, E, Bessette, L, Marrache, M, Lavie, F, Shawi, M, Tillett, W
مصطلحات موضوعية: Clinical sciences, Immunology, Science & Technology, Life Sciences & Biomedicine, Rheumatology
الوقت: 2023-05-31 to 2023-06-03
العلاقة: Annals of the Rheumatic Diseases; EULAR 2023 European Congress of Rheumatology, 31 May - 3 June. Milan, Italy; EULAR 2023 European Congress of Rheumatology; Rahman, P; Coates, L; Nash, P; Deodhar, A; Nantel, F; Rampakakis, E; Bessette, L; Marrache, M; Lavie, F; Shawi, M; Tillett, W, Disagreement Between Patient and Physician Global Assessment Over Time in Psoriatic Arthritis: Insight Into Treatment Priorities, Annals of the Rheumatic Diseases, 2023, 82 (Suppl 1), pp. 345-346; http://hdl.handle.net/10072/429792Test
الإتاحة: https://doi.org/10.1136/annrheumdis-2023-eular.464Test
http://hdl.handle.net/10072/429792Test -
4مؤتمر
المؤلفون: Mease, PJ, Baraliakos, X, Chandran, V, Soriano, E, Nash, P, Deodhar, A, Rampakakis, E, Shiff, N, Chakravarty, SD, Shawi, M, Merola, JF, Mcinnes, I
مصطلحات موضوعية: Clinical sciences, Immunology, Science & Technology, Life Sciences & Biomedicine, Rheumatology, Clinical trials, Psoriatic arthritis
الوقت: 2023-05-31 to 2023-06-03
العلاقة: Annals of the Rheumatic Diseases; EULAR 2023 European Congress of Rheumatology, 31 May - 3 June. Milan, Italy; EULAR 2023 European Congress of Rheumatology; Mease, PJ; Baraliakos, X; Chandran, V; Soriano, E; Nash, P; Deodhar, A; Rampakakis, E; Shiff, N; Chakravarty, SD; Shawi, M; Merola, JF; Mcinnes, I, Effect of Guselkumab Administered Every 8 Weeks in Patients With Active Psoriatic Arthritis Persists Between Consecutive Doses and is Durable: Post Hoc Analysis of a Phase 3, Randomized, Double-blind, Placebo-controlled Study, Annals of the Rheumatic Diseases, 2023, 82, pp. 1782-1783; http://hdl.handle.net/10072/429796Test
الإتاحة: https://doi.org/10.1136/annrheumdis-2023-eular.642Test
http://hdl.handle.net/10072/429796Test -
5مؤتمر
المؤلفون: Bessette, L., Sampalis, J., Haraoui, B., Rampakakis, E., Keating, D., Trepanier, M. O., Pope, J.
المصدر: Scientific Abstracts
-
6مؤتمر
المؤلفون: Pope, J., Sampalis, J., Haraoui, B., Rampakakis, E., Allum, F., Trepanier, M. O., Bessette, L.
المصدر: Scientific Abstracts
-
7مؤتمر
المؤلفون: Aletaha, D., Merola, J. F., Sharaf, M., Shiff, N. J., Rampakakis, E., Nantel, F., Lavie, F., Moltó, A., Ogdie, A.
المصدر: Scientific Abstracts
-
8مؤتمر
المؤلفون: Coates, L. C., Schett, G., D’agostino, M. A., Ramírez, J., Sharaf, M., Rampakakis, E., Koivunen, M., Zimmermann, M., Lavie, F., Helliwell, P. S.
المصدر: Scientific Abstracts
-
9مؤتمر
المؤلفون: Coates, L, Gossec, L, Contre, C, Shawi, M, Rampakakis, E, Shiff, N, Kollmeier, A, Xu, XL, Nash, P, Mease, PJ, Helliwell, P
مصطلحات موضوعية: Pharmacology and pharmaceutical sciences, Rheumatology and arthritis, Life Sciences & Biomedicine, Rheumatology, Science & Technology
جغرافية الموضوع: Copenhagen, Denmark
الوقت: 2022-06-01 to 2022-06-04
العلاقة: Annals of the Rheumatic Diseases; EULAR 2022 European Congress of Rheumatology; Coates, L; Gossec, L; Contre, C; Shawi, M; Rampakakis, E; Shiff, N; Kollmeier, A; Xu, XL; Nash, P; Mease, PJ; Helliwell, P, Guselkumab Provides Continued Improvement in Key Domains of Psoriatic Arthritis Through 2 Years, Annals of the Rheumatic Diseases, 2022, 81 (Suppl 1), pp. 818-819; http://hdl.handle.net/10072/422394Test
الإتاحة: https://doi.org/10.1136/annrheumdis-2022-eular.902Test
http://hdl.handle.net/10072/422394Test -
10مؤتمر
المؤلفون: Mease, PJ, Soriano, E, Chakravarty, SD, Rampakakis, E, Shawi, M, Nash, P, Rahman, P
مصطلحات موضوعية: Pain, Autoimmunity, Pharmacology and pharmaceutical sciences, Life Sciences & Biomedicine, Rheumatology, Science & Technology
جغرافية الموضوع: Copenhagen, Denmark
الوقت: 2022-06-01 to 2022-06-04
العلاقة: Annals of the Rheumatic Diseases; EULAR 2022 European Congress of Rheumatology; Mease, PJ; Soriano, E; Chakravarty, SD; Rampakakis, E; Shawi, M; Nash, P; Rahman, P, Pain Response in Psoriatic Arthritis Patients Treated With Guselkumab is Driven Predominantly by Inflammation-independent Effects, Annals of the Rheumatic Diseases, 2022, 81 (Suppl 1), pp. 828-828; http://hdl.handle.net/10072/422390Test
الإتاحة: https://doi.org/10.1136/annrheumdis-2022-eular.1384Test
http://hdl.handle.net/10072/422390Test